NHS AI slashes invasive womb cancer procedures
nhs hospitals will deploy an ai blood test to prioritize 90k annual referrals, reducing invasive biopsies for low-risk patients.
the nhs plans to implement an ai blood test at several hospitals to assess the risk of womb cancer in postmenopausal women presenting with heavy bleeding. out of 90,000 annual referrals, the ai will help identify patients who require invasive diagnostic procedures like biopsies and those who do not. this application of ai in diagnostics promises to streamline clinical pathways and significantly reduce physical discomfort and anxiety for low-risk patients.